《Cannabis And Cannabinoid Research》是一本由MARY ANN LIEBERT, INC出版商出版的专业医学期刊,刊期6 issues/year,该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:药学 1区;在JCR(Journal Citation... Journal Of Clinical And Translational Hepatology 《...
The prevalence of adults who consume cannabis while abstaining from other substances is not known in the USA. This study used nationally representative data to estimate the prevalence and explore the demographic characteristics, cannabis use behaviors, and self-reported health of US adults with past ...
Cannabis sativa,native to Eastern Asia, was probably first cultivated in China (circa2700 BC) for its medicinal properties. It is a potentially profitable, multi-use crop that has good sustainability credentials due to its low environmental impact (Ranalli and Venturi2004). Hemp seed is highly nu...
Cannabis has been integral to Eurasian civilization for millennia, but a century of prohibition has limited investigation. With spreading legalization, science is pivoting to study the pharmacopeia of the cannabinoids, and a thorough understanding of the
This new development coming from our neighbor to the north could lead to a breakthrough in the cannabis lab testing and research space. CBDV claims they can now analyze cannabis material with a much more in-depth analysis than basic compliance testing labs. The new technology for analysis of ...
2025Journal of Cannabis Research doi:10.1186/s42238-024-00257-5pmid:39849662 As the human cannabinoid (CBD) market grows, there is an inevitable transfer of the same or similar products into the veterinary sector. Advances in veterinary medicine and care of companion animals has led to extended ...
and Experimental TherapeuticsUSA45%similarity9 Cannabis and Cannabinoid ResearchUSA44%similarity10 Biochemical PharmacologyUSA43%similarity11 Folia Pharmacologica JaponicaJPN43%similarity12 Pharmacology and TherapeuticsUSA42%similarity13 Physiological ReviewsUSA42%similarity14 Prostaglandins and Other Lipid MediatorsUSA...
but the decrease is often slight and is achieved with an adverse effect burden that will not be tolerable over weeks to months." [44] Cannabis and cannabinoid research is in its relative infancy and many studies are of short duration and with small sample sizes [6]. However, a number of...
in cannabis from the university standpoint. The National Institute of Health has a program that’s getting kicked off for cannabis research. And they all understand and recognize that the fact we don’t have enough clinical data available is a major hindrance to the advancement of this industry...
The substitution of cannabis for alcohol and other drugs has been conceptualised in a harm reduction framework as where cannabis is used to reduce the negative side-effects, addiction potential, and social stigma of other drugs. There is currently mixed